ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 514 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
 


 

 
     
    Advanced search
 

 
 
     
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
   Introduction
   Diagnosis
   Demographics
   Etiopathogenesis
    Management and P...
    Conclusions and ...
    References
    Article Tables

 Article Access Statistics
    Viewed196    
    Printed5    
    Emailed0    
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents
REVIEW ARTICLE  
Year : 2019  |  Volume : 22  |  Issue : 3  |  Page : 309-315
Perioperative takotsubo cardiomyopathy: Implications for anesthesiologist


Department of Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA

Click here for correspondence address and email

Date of Web Publication4-Jul-2019
 

   Abstract 


Takotsubo cardiomyopathy (TCM) is characterized by transient ventricular dysfunction in the absence of obstructive coronary artery disease that may be triggered by an acute medical illness or intense physical or emotional stress. TCM is often confused with acute myocardial infarction given the similar electrocardiographic changes, cardiac enzymes, hemodynamic perturbations, and myocardial wall motion abnormalities. In the perioperative setting, the clinical picture may be more confusing because of the effect of anesthesia as well as hemodynamic changes related to the surgery itself. However, awareness of various other diagnostic modalities may enable clinicians to distinguish between the two, more systematically and with greater certainty. Despite the large body of literature, there still seems to be an overall paucity in our understanding of the etiopathogenesis, clinical characteristics, natural history, and management of this syndrome, especially in the perioperative setting. This narrative review seeks to present and synthesize the most recent literature on TCM and to identify gaps in current knowledge which can become the basis for future research.

Keywords: Perioperative, stress, surgery, takotsubo cardiomyopathy

How to cite this article:
Agarwal S, Sanghvi C, Odo N, Castresana MR. Perioperative takotsubo cardiomyopathy: Implications for anesthesiologist. Ann Card Anaesth 2019;22:309-15

How to cite this URL:
Agarwal S, Sanghvi C, Odo N, Castresana MR. Perioperative takotsubo cardiomyopathy: Implications for anesthesiologist. Ann Card Anaesth [serial online] 2019 [cited 2019 Jul 19];22:309-15. Available from: http://www.annals.in/text.asp?2019/22/3/309/262106





   Introduction Top


Takotsubo cardiomyopathy (TCM) refers to a syndrome characterized by transient left ventricular (LV) dysfunction but without evidence of obstructive coronary artery disease (CAD).[1] First described in the 1990s in Japan delineating a stunned myocardium in the setting of multivessel coronary artery spasm,[2] “takotsubo” refers to Japanese ceramic pot used to trap octopuses, which resembles the most common LV conformation associated with this disorder, with apical akinesis and basal hyperkinesis.[3] As the reported incidence of this cardiomyopathy has since risen worldwide, it has taken on multiple names such as apical ballooning syndrome, broken heart syndrome, and stress-induced cardiomyopathy. Stressors that can trigger this cardiomyopathy may be emotional or physical.[4] It has been noted in outpatient and inpatient scenarios, critical care units, and the perioperative environment.[5] This narrative review is an attempt to synthesize the literature and identify gaps in our current understanding of the pathophysiology, clinical characteristics, natural history, and management of this syndrome, especially in the perioperative setting.

For this review, a MEDLINE database search was performed using the following Medical Subject Headings terms: takotsubo cardiomyopathy, ampulla cardiomyopathy, anesthesia cardiomyopathy, broken heart syndrome, stress-induced cardiomyopathy, transient left ventricular apical ballooning syndrome, and transient midventricular ballooning. These were combined with the following: anaesthesia, anesthesia, intraoperative, perioperative, postoperative, after surgery, and during surgery. A Web of Science search was then performed using similar terms. Additional references were then identified by manual search of the articles obtained from MEDLINE and Web of Science. With the exception of a 1991 publication, the searches covered the period from January 2000 to February 2018.


   Diagnosis Top


Numerous diagnostic criteria have been proposed for TCM[4],[6],[7],[8],[9],[10],[11],[12] [Table 1]; however, the revised Mayo Clinic criteria published in 2008[7] is still the most widely cited and probably the criteria against which most scientific work has been compared. While the recent European Society of Cardiology Criteria[12] has more comprehensive and extensive factors, it has yet to achieve widespread acceptance. Furthermore, there is often confusion between acute myocardial infarction (AMI) and TCM given the similarities in electrocardiographic (EKG) changes, cardiac enzymes, hemodynamic perturbations, and myocardial wall motional abnormalities. However, a deeper insight into the differences noted on various diagnostic modalities can help distinguish TCM from AMI.
Table 1: Perioperative triggers of takotsubo cardiomyopathy

Click here to view


Electrocardiographic changes

A combination of ST-segment depression >0.5 mm in lead aVR and ST-segment elevation ≤1 mm in lead V1 has shown very high sensitivity (91%), specificity (96%), and positive predictive accuracy (95%) in identifying TCM.[13] However, these findings could not be reaffirmed in subsequent studies by Johnson et al.[14] (0%, 99%, and 88%) and Vervaat et al.[15] (26%, 96%, and 76%), who found high specificity but extremely low sensitivity and slightly lower positive predictive values. Some investigators found a lower maximal ST elevation (2 mm vs. 3 mm) in a greater number of leads with ST elevation in TCM patients compared with those with AMI.[13],[16]

A recent study by Namgung found two different EKG patterns representative of TCM: ST elevation followed by T-wave inversions after ST elevations have subsided and more commonly T-wave inversions alone without associated ST elevations but associated with QTc prolongations.[17] This suggests that reviewing the timeline of EKG changes may be more valuable than a single snapshot (i.e., EKG at initial presentation).

In the perioperative period, electrolyte abnormalities can occur, which may influence and/or mask EKG findings. Along with that, for a true intraoperative event, obtaining a 12-lead EKG may not be immediately feasible, and since the consequences of a missed diagnosis of AMI can be omnious, it may be necessary to include other parameters to guide the diagnosis of TCM.

Cardiac enzymes

In most cases of TCM, cardiac biomarkers are elevated. In the large International Takotsubo Registry, a consortium of 26 centers in Europe and the United States, median troponin levels on admission were 7.7 times the normal range and creatinine kinase levels were normal or slightly elevated at 0.85 times the normal range. It is important, however, to note that the troponin elevation was much lower in TCM as compared to AMI.[18],[19]

Recently, a new noninvasive tool called the troponin-ejection fraction product derived from the peak troponin I level and the echocardiographically derived LV ejection fraction has been developed and tested for patients who for whatever reason do not undergo emergent angiography.[20] A value ≥250 had a high overall accuracy of 91% to differentiate an AMI from a TCM.[20] Several other biomarkers in the combination including the ratio of the N-terminal prohormone of brain natriuretic peptide over myoglobin or troponin T may also aid in this differentiation.[21]

Echocardiographic findings

Transthoracic echocardiography, or in the perioperative setting, transesophageal echocardiography, is usually the first noninvasive imaging technique used to diagnose TCM. This is done to assess LV function and the pattern of regional wall motion abnormalities (RWMAs) to help identify TCM variants. It also aids in early recognition of any LV outflow tract obstruction and/or mitral regurgitation, which may influence management and outcomes.[22],[23]

The classic RWMAs associated with TCM include systolic mid-LV and apical hypokinesis or dyskinesis with preservation or hypercontractility of the LV basal segments. The LV dysfunction usually extends beyond a single coronary artery distribution. This produces the apical ballooning that is characteristically identified with TCM. Some variants of this presentation include midventricular, basal, focal, or global hypokinesis.[18] While most TCM cases have transient LV systolic dysfunction, however, right ventricular involvement has been noted in 25%–42% of the TCM population.[24],[25]

Coronary angiography and other imaging modalities

Given the similarity in presentations between AMI and TCM, it is important to obtain appropriate imaging that will assist in ruling out obstructive CAD to guide the necessary intervention. Cardiac catheterization has been utilized as a confirmatory test for the diagnosis of TCM. In patients with TCM, coronary angiography will most likely reveal normal coronary arteries. It is important to note that 10% of TCM cases may also have coexisting obstructive CAD.[26] Therefore, delineating whether the obstructive lesion is the cause of the RWMA becomes vital to determine which management strategy needs to be employed.[23]

In cases with coexistent CAD or an echocardiogram with poor visualization, cardiovascular magnetic resonance (CMR) imaging can be utilized.[27] The absence of late gadolinium enhancement on CMR provides evidence against AMI and myocarditis.[28] CMR can help identify a ventricular thrombus or involvement of the right ventricle that may not be easily visualized on echocardiogram.[24],[29] An imaging technique, but one that is not as widely used for the diagnosis of TCM, is positron-emission tomography. A phenomenon known as “inverse flow-metabolism mismatch” due to a discrepancy between normal perfusion and limited glucose metabolism in dysfunctional areas is seen in myocardial positron-emission tomographic scans of TCM patients.[30]


   Demographics Top


As per a registry of 3265 patients, approximately 1% of patients presenting with acute coronary syndrome were found to have TCM.[31] Based on the estimated US census in 2008 and Nationwide Inpatient Sample database, there is a stronger overall female predominance for TCM (5.2 per for every 100,000 females versus 0.6 for every 100,000 males).[32] This was further corroborated by the 84.3% incidence in females of perioperative TCM as reported by Agarwal et al., with a similar higher proportion in the elderly age bracket.[33] Furthermore, similar to nonperioperative TCM, a stronger Caucasian predilection was observed in those presenting in the perioperative period.[33]


   Etiopathogenesis Top


Defining the specific pathogenesis for TCM has been an elusive task. Multiple theories have been proposed including coronary artery vasospasm, microvascular dysfunction, and postacute coronary syndrome reperfusion injury.[34],[35],[36] One of the most prominent theories focuses on excess catecholamine surge during emotional or physical stress activating beta- and alpha-adrenergic receptors and causing microvascular spasm that eventually precipitates myocyte injury.[37],[38] This is supported by myocardial biopsies showing contraction band necrosis, inflammatory cell infiltration, and interstitial fibrosis; these histological findings are associated with catecholamine-induced injury.[39]

Furthermore, given the predilection of TCM among postmenopausal women, a lack of estrogen has been considered a significant risk factor. Estrogen induces production of heat shock protein and atrial natriuretic peptide, both of which are thought to be cardioprotective against the adverse effects of catecholamine surge and oxidative stress.[40] A systematic literature review found that none of the cases of TCM was being treated with estrogen replacement therapy.[41]

Myocardial oxidative stress may be another contributory factor for the transient LV dysfunction noted in TCM. Nanno et al. noted elevated levels of 8-hydroxy-2′-deoxyguanosine (used as a marker of oxidative stress) associated with increased levels of norepinephrine in TCM patients.[42] Furthermore, oxidative stress causes upregulation of heme oxygenase-1 in cardiac and aortic macrophages secondary to catecholamine crisis in animal models of TCM.[43] Myocardial injury could be purported due to free radical regeneration, calcium overload, and calcium retention in the sarcoplasmic reticulum causing excitation–contraction uncoupling.[29]

A recently published systematic review of TCM cases reported that surgery can be psychologically and emotionally taxing[33] and that numerous nonpsychological factors in the perioperative period may contribute to the development of this condition [Table 2].[44],[45],[46],[47],[48],[49],[50],[51],[52],[53] However, given the intense stress experienced by most patients undergoing surgery, and the large number of surgeries being performed across the world, cardioprotective effects of volatile agents may have a bearing on the relatively low incidence of perioperative TCM. While there is now a body of evidence from animal andin vitro studies of human myocardial tissue suggestive of ischemic preconditioning properties of volatile anesthetics,[54] its actual role in the pathogenesis and prevention of perioperative TCM needs further exploration.
Table 2: Comprehensive timeline of diagnostic criteria for takotsubo cardiomyopathy

Click here to view


Furthermore, given that only a miniscule proportion of all the perimenopausal women undergoing surgery develop TCM, there has been some recent interest toward delineating the role of genetics in this condition. This interest has stemmed largely from reports of familial cases of TCM, nonstress triggered TCM (especially in premenopausal females), and recurring TCM episodes.[55],[56],[57],[58] Polymorphisms in genes for the alpha 1-, beta 1-, and beta 2-adrenergic receptors as well as the G protein-coupled receptor kinase 5 are being investigated for a link to TCM; however, no conclusive evidence has been found.[58],[59],[60] Eitel et al. recently conducted the first genome-wide association study for TCM locating 68 candidate loci,[61] and some preliminary studies have also reported an association with estrogen receptor polymorphisms in both the ESR1 and ESR2 genes.[62] However, it is important to note that larger population studies are necessary to provide statistically significant genetic links for TCM.


   Management and Prognosis Top


Randomized controlled trials of specific therapeutic strategies are lacking, and thus, TCM management is driven by the understanding of the pathophysiology.[7],[63] Given the reversible effects of cardiac injury, the interim management focuses on supportive care and prevention of severe complications.[64] Initial management of acute-phase TCM is similar to AMI given the similarity in presentation with aspirin, heparin, and antiplatelet therapy. Hemodynamically stable patients are managed with beta-blockers, angiotensin-converting enzyme inhibitors (ACE-Is) or angiotensin-receptor blockers (ARBs), and diuretics. For patients with severe LV outflow obstruction, treatment involves beta-blockers, α-agonists, and/or calcium channel blockers along with volume expansion; nitrites and inotropic agents are avoided in this scenario. Furthermore, anticoagulation may be initiated for patients with apical dysfunction for the prevention of thrombus formation.[36] For severely unstable patients, intra-aortic balloon pump along with extracorporeal membrane oxygenation or temporary ventricular-assisted devices may be necessary.[65]

Perioperative management of TCM involves an intricate interplay of several key factors. Elective procedures in patients with known TCM are often delayed until resolution of the cardiomyopathy. If psychological risk factors, e.g., death in the family or divorce, have been identified during the preoperative assessment, then delaying an elective surgery may be prudent. For nonelective cases, extra focus on allaying anxiety and stress may help in preventing a TCM episode. If feasible, regional anesthesia with appropriate sedation should be employed since it affords the ability to avoid general anesthesia-associated stress (with intubation and extubation) and provides postoperative pain control.[66] Irrespective of the anesthetic management employed, avoidance of stressors that could trigger a catecholamine surge is vital through appropriate pain management and preoperative anxiolysis as well as smooth induction and emergence. Prophylactic beta-blocker therapy should be given. Furthermore, invasive monitoring may be required including arterial line and transthoracic or transesophageal echocardiography. Many of these patients may require observation overnight in an intensive care unit given the potential for a TCM episode in the immediate postoperative period.[23],[67]

Although a favorable prognosis and fast recovery are observed for most patients with TCM that survive the acute episode, it is important to note that mortality risk in TCM is similar to patients with AMI. Templin et al. reported a 30-day risk of major adverse cardiac and cerebrovascular events of 5.9%. Furthermore, the mortality rate per year was 5.6%, and the rate of stroke or transient ischemic attack was 1.7%.[18] Studies indicate that the annual recurrence rate of TCM is about 1-2%, with ACEi/ARBs having a stronger impact in reduction of recurrence when compared to beta-blockers.[68]


   Conclusions and Future Directions Top


As the body of knowledge has expanded, we have become more proficient at the diagnosis and treatment of TCM, in general, and perioperative TCM, in particular. However, well-planned controlled clinical trials are needed to test various diagnostic and treatment regimens. Clinical trials are also needed to provide sufficient evidence to enable agreement on a single set of criteria with which to define TCM along with dedicated criteria for the perioperative setting. Such rigorous testing will enable the development of guidelines to suggest treatments specific to the degree of hemodynamic stability of each individual patient. If such guidelines are followed by practitioners on a wide scale, then not only will more patients be treated expeditiously and appropriately, but the likelihood of life-threatening cardiac and cerebrovascular events that could occur after a TCM would also be reduced. Simultaneous research to better understand the cardioprotective effects of volatile agents as well as the genetic links if any may help not only to prevent TCM perioperatively by tailoring the anesthetic management but also to aid in the identification of those susceptible to this syndrome in the future.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Liu S, Dhamee MS. Perioperative transient left ventricular apical ballooning syndrome: Takotsubo cardiomyopathy: A review. J Clin Anesth 2010;22:64-70.  Back to cited text no. 1
    
2.
Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: A review of 5 cases. J Cardiol 1991;21:203-14.  Back to cited text no. 2
    
3.
Aizawa K, Suzuki T. Takotsubo cardiomyopathy: Japanese perspective. Heart Fail Clin 2013;9:243-7, x.  Back to cited text no. 3
    
4.
Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004;141:858-65.  Back to cited text no. 4
    
5.
Hessel EA 2nd. Takotsubo cardiomyopathy and its relevance to anesthesiology: A narrative review. Can J Anaesth 2016;63:1059-74.  Back to cited text no. 5
    
6.
Kawai S, Kitabatake A, Tomoike H; Takotsubo Cardiomyopathy Group. Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J 2007;71:990-2.  Back to cited text no. 6
    
7.
Prasad A. Apical ballooning syndrome: An important differential diagnosis of acute myocardial infarction. Circulation 2007;115:e56-9.  Back to cited text no. 7
    
8.
Schultz T, Shao Y, Redfors B, Sverrisdóttir YB, Råmunddal T, Albertsson P, et al. Stress-induced cardiomyopathy in Sweden: Evidence for different ethnic predisposition and altered cardio-circulatory status. Cardiology 2012;122:180-6.  Back to cited text no. 8
    
9.
Wittstein IS. Stress cardiomyopathy: A syndrome of catecholamine-mediated myocardial stunning? Cell Mol Neurobiol 2012;32:847-57.  Back to cited text no. 9
    
10.
Redfors B, Shao Y, Omerovic E. Stress-induced cardiomyopathy (Takotsubo) – Broken heart and mind? Vasc Health Risk Manag 2013;9:149-54.  Back to cited text no. 10
    
11.
Parodi G, Citro R, Bellandi B, Provenza G, Marrani M, Bossone E, et al. Revised clinical diagnostic criteria for Tako-tsubo syndrome: The Tako-tsubo Italian network proposal. Int J Cardiol 2014;172:282-3.  Back to cited text no. 11
    
12.
Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, et al. Current state of knowledge on takotsubo syndrome: A position statement from the taskforce on Takotsubo syndrome of the heart failure association of the European Society of Cardiology. Eur J Heart Fail 2016;18:8-27.  Back to cited text no. 12
    
13.
Kosuge M, Ebina T, Hibi K, Morita S, Okuda J, Iwahashi N, et al. Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol 2010;55:2514-6.  Back to cited text no. 13
    
14.
Johnson NP, Chavez JF, Mosley WJ 2nd, Flaherty JD, Fox JM. Performance of electrocardiographic criteria to differentiate takotsubo cardiomyopathy from acute anterior ST elevation myocardial infarction. Int J Cardiol 2013;164:345-8.  Back to cited text no. 14
    
15.
Vervaat FE, Christensen TE, Smeijers L, Holmvang L, Hasbak P, Szabó BM, et al. Is it possible to differentiate between takotsubo cardiomyopathy and acute anterior ST-elevation myocardial infarction? J Electrocardiol 2015;48:512-9.  Back to cited text no. 15
    
16.
Looi JL, Wong CW, Lee M, Khan A, Webster M, Kerr AJ, et al. Usefulness of ECG to differentiate takotsubo cardiomyopathy from acute coronary syndrome. Int J Cardiol 2015;199:132-40.  Back to cited text no. 16
    
17.
Namgung J. Electrocardiographic findings in takotsubo cardiomyopathy: ECG evolution and its difference from the ECG of acute coronary syndrome. Clin Med Insights Cardiol 2014;8:29-34.  Back to cited text no. 17
    
18.
Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of takotsubo (Stress) cardiomyopathy. N Engl J Med 2015;373:929-38.  Back to cited text no. 18
    
19.
Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E, et al. Apical ballooning syndrome or takotsubo cardiomyopathy: A systematic review. Eur Heart J 2006;27:1523-9.  Back to cited text no. 19
    
20.
Nascimento FO, Yang S, Larrauri-Reyes M, Pineda AM, Cornielle V, Santana O, et al. Usefulness of the troponin-ejection fraction product to differentiate stress cardiomyopathy from ST-segment elevation myocardial infarction. Am J Cardiol 2014;113:429-33.  Back to cited text no. 20
    
21.
Fröhlich GM, Schoch B, Schmid F, Keller P, Sudano I, Lüscher TF, et al. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. Int J Cardiol 2012;154:328-32.  Back to cited text no. 21
    
22.
Bossone E, Lyon A, Citro R, Athanasiadis A, Meimoun P, Parodi G, et al. Takotsubo cardiomyopathy: An integrated multi-imaging approach. Eur Heart J Cardiovasc Imaging 2014;15:366-77.  Back to cited text no. 22
    
23.
Weiner MM, Asher DI, Augoustides JG, Evans AS, Patel PA, Gutsche JT, et al. Takotsubo cardiomyopathy: A clinical update for the cardiovascular anesthesiologist. J Cardiothorac Vasc Anesth 2017;31:334-44.  Back to cited text no. 23
    
24.
Haghi D, Athanasiadis A, Papavassiliu T, Suselbeck T, Fluechter S, Mahrholdt H, et al. Right ventricular involvement in takotsubo cardiomyopathy. Eur Heart J 2006;27:2433-9.  Back to cited text no. 24
    
25.
Elesber AA, Prasad A, Bybee KA, Valeti U, Motiei A, Lerman A, et al. Transient cardiac apical ballooning syndrome: Prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol 2006;47:1082-3.  Back to cited text no. 25
    
26.
Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakama Y, et al. Prevalence of incidental coronary artery disease in tako-tsubo cardiomyopathy. Coron Artery Dis 2009;20:214-8.  Back to cited text no. 26
    
27.
Brito D, Ibrahim MA. Cardiomyopathy, Takotsubo Syndrome (Transient Apical Ballooning, Stress-Induced Cardiomyopathy, Gebrochenes-Herz Syndrome). Treasure Island (FL): StatPearls; 2017.  Back to cited text no. 27
    
28.
Daoko J, Rajachandran M, Savarese R, Orme J. Biventricular takotsubo cardiomyopathy: Case study and review of literature. Tex Heart Inst J 2013;40:305-11.  Back to cited text no. 28
    
29.
Roshanzamir S, Showkathali R. Takotsubo cardiomyopathy a short review. Curr Cardiol Rev 2013;9:191-6.  Back to cited text no. 29
    
30.
Testa M, Feola M. Usefulness of myocardial positron emission tomography/nuclear imaging in takotsubo cardiomyopathy. World J Radiol 2014;6:502-6.  Back to cited text no. 30
    
31.
Kurowski V, Kaiser A, von Hof K, Killermann DP, Mayer B, Hartmann F, et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): Frequency, mechanisms, and prognosis. Chest 2007;132:809-16.  Back to cited text no. 31
    
32.
Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL, et al. Prevalence of takotsubo cardiomyopathy in the United States. Am Heart J 2012;164:66-710.  Back to cited text no. 32
    
33.
Agarwal S, Bean MG, Hata JS, Castresana MR. Perioperative takotsubo cardiomyopathy: A systematic review of published cases. Semin Cardiothorac Vasc Anesth 2017;21:277-90.  Back to cited text no. 33
    
34.
Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of takotsubo syndrome. Circulation 2017;135:2426-41.  Back to cited text no. 34
    
35.
Vitale C, Rosano GM, Kaski JC. Role of coronary microvascular dysfunction in takotsubo cardiomyopathy. Circ J 2016;80:299-305.  Back to cited text no. 35
    
36.
Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T. Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment. World J Cardiol 2014;6:602-9.  Back to cited text no. 36
    
37.
Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS, et al. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009;53:1320-5.  Back to cited text no. 37
    
38.
Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48.  Back to cited text no. 38
    
39.
Nef HM, Möllmann H, Kostin S, Troidl C, Voss S, Weber M, et al. Tako-tsubo cardiomyopathy: Intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007;28:2456-64.  Back to cited text no. 39
    
40.
Ueyama T, Hano T, Kasamatsu K, Yamamoto K, Tsuruo Y, Nishio I, et al. Estrogen attenuates the emotional stress-induced cardiac responses in the animal model of tako-tsubo (Ampulla) cardiomyopathy. J Cardiovasc Pharmacol 2003;42 Suppl 1:S117-9.  Back to cited text no. 40
    
41.
Kuo BT, Choubey R, Novaro GM. Reduced estrogen in menopause may predispose women to takotsubo cardiomyopathy. Gend Med 2010;7:71-7.  Back to cited text no. 41
    
42.
Nanno T, Kobayashi S, Oda S, Ishiguchi H, Myoren T, Oda T, et al. Relationship between cardiac sympathetic hyperactivity and myocardial oxidative stress in patients with takotsubo cardiomyopathy. J Card Fail 2015;21:S146-S.  Back to cited text no. 42
    
43.
Ueyama T, Kawabe T, Hano T, Tsuruo Y, Ueda K, Ichinose M, et al. Upregulation of heme oxygenase-1 in an animal model of takotsubo cardiomyopathy. Circ J 2009;73:1141-6.  Back to cited text no. 43
    
44.
Jakobson T, Svitškar N, Tamme K, Starkopf J, Karjagin J. Two cases of takotsubo syndrome related to tracheal intubation/extubation. Medicina (Kaunas) 2012;48:77-9.  Back to cited text no. 44
    
45.
Attisani M, Campanella A, Boffini M, Rinaldi M. Takotsubo cardiomyopathy after minimally invasive mitral valve surgery: Clinical case and review. J Heart Valve Dis 2013;22:675-81.  Back to cited text no. 45
    
46.
Behnes M, Baumann S, Borggrefe M, Haghi D. Biventricular takotsubo cardiomyopathy in a heart transplant recipient. Circulation 2013;128:e62-3.  Back to cited text no. 46
    
47.
Dewachter P, Tanase C, Levesque E, Nicaise-Roland P, Chollet-Martin S, Mouton-Faivre C, et al. Apical ballooning syndrome following perioperative anaphylaxis is likely related to high doses of epinephrine. J Anesth 2011;25:282-5.  Back to cited text no. 47
    
48.
Gologorsky E, Gologorsky A. Intraoperative stress cardiomyopathy. J Am Soc Echocardiogr 2010;23:340.e3-4.  Back to cited text no. 48
    
49.
Lee SH, Chang CH, Park JS, Nam SB. Stress-induced cardiomyopathy after negative pressure pulmonary edema during emergence from anesthesia – A case report. Korean J Anesthesiol 2012;62:79-82.  Back to cited text no. 49
    
50.
Keskin A, Winkler R, Mark B, Kilkowski A, Bauer T, Koeth O, et al. Tako-tsubo cardiomyopathy after administration of ergometrine following elective caesarean delivery: A case report. J Med Case Rep 2010;4:280.  Back to cited text no. 50
    
51.
Lieb M, Orr T, Gallagher C, Moten H, Tan JM. A case of intra-operative ventricular fibrillation: Electro-cauterization, undiagnosed takotsubo cardiomyopathy or long QT syndrome? Int J Surg Case Rep 2012;3:155-7.  Back to cited text no. 51
    
52.
Meng L, Wells C. Takotsubo cardiomyopathy during emergence from general anaesthesia. Anaesth Intensive Care 2009;37:836-9.  Back to cited text no. 52
    
53.
O'Reardon JP, Lott JP, Akhtar UW, Cristancho P, Weiss D, Jones N, et al. Acute coronary syndrome (Takotsubo cardiomyopathy) following electroconvulsive therapy in the absence of significant coronary artery disease: Case report and review of the literature. J ECT 2008;24:277-80.  Back to cited text no. 53
    
54.
Kunst G, Klein AA. Peri-operative anaesthetic myocardial preconditioning and protection – Cellular mechanisms and clinical relevance in cardiac anaesthesia. Anaesthesia 2015;70:467-82.  Back to cited text no. 54
    
55.
Pison L, De Vusser P, Mullens W. Apical ballooning in relatives. Heart 2004;90:e67.  Back to cited text no. 55
    
56.
Kumar G, Holmes DR Jr., Prasad A. “Familial” apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol 2010;144:444-5.  Back to cited text no. 56
    
57.
Ikutomi M, Yamasaki M, Matsusita M, Watari Y, Arashi H, Endo G, et al. Takotsubo cardiomyopathy in siblings. Heart Vessels 2014;29:119-22.  Back to cited text no. 57
    
58.
Limongelli G, Masarone D, Maddaloni V, Rubino M, Fratta F, Cirillo A, et al. Genetics of takotsubo syndrome. Heart Fail Clin 2016;12:499-506.  Back to cited text no. 58
    
59.
Limongelli G, D'Alessandro R, Masarone D, Maddaloni V, Vriz O, Minisini R, et al. Takotsubo cardiomyopathy: Do the genetics matter? Heart Fail Clin 2013;9:207-16, ix.  Back to cited text no. 59
    
60.
Vriz O, Minisini R, Citro R, Guerra V, Zito C, De Luca G, et al. Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy. Acta Cardiol 2011;66:787-90.  Back to cited text no. 60
    
61.
Eitel I, Moeller C, Munz M, Stiermaier T, Meitinger T, Thiele H, et al. Genome-wide association study in takotsubo syndrome – Preliminary results and future directions. Int J Cardiol 2017;236:335-9.  Back to cited text no. 61
    
62.
Pizzino G, Bitto A, Crea P, Khandheria B, Vriz O, Carerj S, et al. Takotsubo syndrome and estrogen receptor genes: Partners in crime? J Cardiovasc Med (Hagerstown) 2017;18:268-76.  Back to cited text no. 62
    
63.
Bietry R, Reyentovich A, Katz SD. Clinical management of takotsubo cardiomyopathy. Heart Fail Clin 2013;9:177-86, viii.  Back to cited text no. 63
    
64.
Tarkin JM, Khetyar M, Kaski JC. Management of tako-tsubo syndrome. Cardiovasc Drugs Ther 2008;22:71-7.  Back to cited text no. 64
    
65.
Gupta S, Gupta MM. Takotsubo syndrome. Indian Heart J 2018;70:165-74.  Back to cited text no. 65
    
66.
Liu S, Bravo-Fernandez C, Riedl C, Antapli M, Dhamee MS. Anesthetic management of takotsubo cardiomyopathy: General versus regional anesthesia. J Cardiothorac Vasc Anesth 2008;22:438-41.  Back to cited text no. 66
    
67.
Barros J, Gomes D, Caramelo S, Pereira M. Perioperative approach of patient with takotsubo syndrome. Rev Bras Anestesiol 2017;67:321-5.  Back to cited text no. 67
    
68.
Singh K, Carson K, Usmani Z, Sawhney G, Shah R, Horowitz J, et al. Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy. Int J Cardiol 2014;174:696-701.  Back to cited text no. 68
    

Top
Correspondence Address:
Shvetank Agarwal
Department of Anesthesiology and Perioperative Medicine, Medical College of Georgia, Augusta University, 1120 15th Street Biw-2144, Augusta, GA 30912
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aca.ACA_71_18

Rights and Permissions



 
 
    Tables

  [Table 1], [Table 2]



 

Top